BIVALIRUDIN for Percutaneous coronary intervention: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 159 adverse event reports in the FDA FAERS database where BIVALIRUDIN was used for Percutaneous coronary intervention.

Most Reported Side Effects for BIVALIRUDIN

Side Effect	Reports	%	Deaths	Hosp.
Drug ineffective	148	17.6%	12	72
Haemorrhage	79	9.4%	7	22
Off label use	73	8.7%	9	35
Thrombosis in device	63	7.5%	9	8
Vascular stent thrombosis	63	7.5%	14	15
Heparin-induced thrombocytopenia	61	7.3%	8	38
Thrombosis	61	7.3%	9	13
Coagulation time abnormal	42	5.0%	3	2
Gastrointestinal haemorrhage	40	4.8%	6	11
Coronary artery thrombosis	33	3.9%	7	4
Cardiac arrest	28	3.3%	25	16
Haemorrhage intracranial	20	2.4%	7	6
Kounis syndrome	20	2.4%	15	11
Acute myocardial infarction	19	2.3%	7	10
Ventricular fibrillation	19	2.3%	13	12